Inspiratory Muscle Training X CardioBreath App Effects On Vagal Modulation And Pulse Wave Velocity (CardioBreath)
Postmenopausal Disorder, Autonomic Imbalance, Vascular Stiffness
About this trial
This is an interventional prevention trial for Postmenopausal Disorder
Eligibility Criteria
Inclusion Criteria:
- Follicle Stimulating Hormone (FSH)>35mui/ml
- minimum 12 months amenorrhea
- sedentary life style (less than 150 minutes per week of exercise)
Exclusion Criteria:
- Hypertension
- Diabetes
- Obesity
- Use of Betablockers
- recent cardiovascular events or surgery
- renal alterations
- respiratory and/or motor pathologies
- smoking
- BMI>29,9
Sites / Locations
- Cardiology Institute of Rio Grande do Sul
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Placebo Comparator
Active Comparator
IMT PowerBreath
IMT PowerBreath Placebo
CardioBreathApp
Participants will have PowerBreath device for IMT adjusted for 30% of maximal inspiratory pressure and will perform the exercise at home for five days/week during 10 minutes for five weeks. An once a week meeting will provide re-adjustment of load through maximal inspiratory pressure performance
Participants will have PowerBreath device for IMT with no load and will perform the exercise at home for five days/week during 10 minutes for five weeks. An once a week meeting will not re-adjustment the load though maximal inspiratory pressure performance will be performed
CardioBreathApp group will have the app settings of profile and spontaneous respiratory rate to determine the exercise rate of exercises, which will be performed at home for five days/week during 10 minutes for five weeks An once a week meeting will provide re-adjustment of respiratory rate to perform exercises